This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Occupational exposure to risk-factors
Z21_OCCUPAT_EXPOS_RISK_
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1393 |
4. Check minimum number of eventsNone |
1393 |
5. Include endpointsNone |
1393 |
6. Filter based on genotype QC (FinnGen only) |
1260 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z5[5-9]|Z6
Similar endpoints
↥List of similar endpoints to
Occupational exposure to risk-factors
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to socioeconomic and psychosocial circumstances
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1260 | 420 | 840 |
| Unadjusted period prevalence (%) | 0.31 | 0.15 | 0.39 |
| Median age at first event (years) | 56.84 | 45.34 | 62.59 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1303
- Matched controls
- 13030
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
36.6
307.7
365
137
Z57.2
ICD-10 Finland
Occupational exposure to dust
+∞
307.7
495
*
Z57.3
ICD-10 Finland
Occupational exposure to other air contaminants
834.9
307.7
364
6
Z57.0
ICD-10 Finland
Occupational exposure to noise
477.6
132.5
130
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.9
130.3
222
374
Z57.8
ICD-10 Finland
Occupational exposure to other risk-factors
361.1
130.0
129
*
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
31.6
126.6
83
28
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.7
107.5
301
788
H83.3
ICD-10 Finland
Noise effects on inner ear
12.2
101.2
104
92
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
5.1
100.3
242
559
Z57.7
ICD-10 Finland
Occupational exposure to vibration
1022.4
98.4
95
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.9
94.7
185
353
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
8.0
89.9
128
175
XQ800
NOMESCO Finland
Prick test
5.0
80.1
189
425
J45.9
ICD-10 Finland
Asthma, unspecified
3.3
74.4
376
1443
XG410
NOMESCO Finland
Flow-volume spirometry
6.0
74.0
139
254
R03AC02
ATC
salbutamol; inhalant
2.8
68.8
866
5347
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.2
68.5
208
568
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
15.9
66.9
58
38
GD1AD
NOMESCO Finland
Thorax CT examination
4.1
60.6
182
491
Z57.9
ICD-10 Finland
Occupational exposure to unspecified risk-factor
+∞
57.7
55
*
R03BA08
ATC
ciclesonide; inhalant
3.7
53.9
192
582
J30.3
ICD-10 Finland
Other allergic rhinitis
5.7
53.9
104
194
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
19.1
49.3
39
21
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
10.2
49.2
56
57
Z57.5
ICD-10 Finland
Occupational exposure to toxic agents in other industries
+∞
48.2
46
*
R06.0
ICD-10 Finland
Dyspnoea
2.4
47.3
466
2438
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
47.1
396
1927
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.7
46.3
89
165
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.5
42.5
328
1524
XG474
NOMESCO Finland
Exhalation nntrogen oxide
5.6
40.6
79
148
XX1XW
NOMESCO Finland
Extensive written report from radiologist
6.3
39.5
68
113
J45.1
ICD-10 Finland
Nonallergic asthma
3.6
39.4
142
431
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
6.2
37.9
66
111
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
37.8
244
1034
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
35.7
733
4988
T75.2
ICD-10 Finland
Effects of vibration
356.5
35.1
35
*
R06.2
ICD-10 Finland
Wheezing
4.0
33.4
99
262
I73.0
ICD-10 Finland
Raynaud syndrome
7.0
33.3
51
75
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.3
32.8
68
135
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.3
32.6
299
1482
H02AB06
ATC
prednisolone; systemic
2.0
32.4
686
4659
Y96.0
ICD-10 Finland
Work-related condition
9.1
31.7
39
44
SPAT1263
SPAT
Sampling
2.0
31.4
588
3814
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.5
31.3
79
185
Z2221
NOMESCO Finland
Medical doctor
0.2
31.0
65
2305
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.9
30.2
155
579
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.6
30.1
192
803
WX720
NOMESCO Finland
Own respiration
3.4
29.3
113
357
ZXD10
NOMESCO Finland
Scheduled procedure
0.4
28.4
155
3383
R03BB04
ATC
tiotropium bromide; inhalant
2.6
28.2
189
809
R03DC03
ATC
montelukast; oral
2.3
27.0
243
1186
R03AK08
ATC
formoterol and beclometasone; inhalant
3.5
26.5
94
281
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
25.9
150
596
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
25.6
118
414
R96
ICPC
Asthma
2.6
25.5
159
656
R4110
NOMESCO Finland
Physiotherapy
0.3
25.2
93
2460
XQ802
NOMESCO Finland
Epicutan test
3.9
24.8
75
201
TGC00
NOMESCO Finland
Bronchial lavation
4.3
24.7
65
157
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.3
24.4
98
317
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
22.4
130
516
R02
ICPC
Shortness of breath/dyspnoea
2.2
21.9
211
1054
WX725
NOMESCO Finland
Noninvasive ventilation
2.8
21.6
111
414
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
21.4
556
3862
J94.8
ICD-10 Finland
Other specified pleural conditions
5.3
21.4
43
83
J92.9
ICD-10 Finland
Pleural plaque without asbestos
6.6
20.5
33
51
R03BA01
ATC
beclometasone; inhalant
2.2
20.3
196
978
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.3
20.1
79
252
SPAT1301
SPAT
No procedures
1.8
18.9
412
2701
ZXE00
NOMESCO Finland
One hour or less
0.5
18.9
203
3541
WX704
NOMESCO Finland
Intubation
2.4
18.4
137
611
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.1
17.8
31
52
ZXE10
NOMESCO Finland
More than one and less than three hours
0.5
17.7
183
3251
Z3231
NOMESCO Finland
Registered nurse
0.4
17.7
112
2382
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.2
17.3
46
112
SPAT1310
SPAT
Counselling related to known health issue
1.7
17.3
416
2791
SPAT1058
SPAT
PEF monitoring instruction
2.5
17.1
114
484
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.8
16.9
85
313
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
3.2
16.8
66
211
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
16.7
200
1077
SPAT1097
SPAT
Recording of ECG
2.0
16.6
205
1116
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.1
16.6
69
228
R03BA05
ATC
fluticasone; inhalant
1.9
16.5
235
1345
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.0
16.4
194
1041
J45
ICD-10 Finland
Asthma
2.2
15.7
141
680
UDC00
NOMESCO Finland
Ear microscopy
2.3
15.4
117
527
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.4
15.3
38
88
R01AD09
ATC
mometasone; nasal
1.6
14.8
558
4156
R04.2
ICD-10 Finland
Haemoptysis
3.0
14.7
64
217
R01AD58
ATC
fluticasone, combinations; nasal
1.7
14.7
314
2025
R95
ICPC
Chron obstructive pulmonary disease
3.1
14.2
61
206
SPAT1153
SPAT
Removal of sutures
1.6
14.1
422
2967
C45.0
ICD-10 Finland
Mesothelioma of pleura
16.0
13.9
22
14
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.6
13.9
26
47
J01AA02
ATC
doxycycline; systemic
1.7
13.8
978
8389
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
13.6
71
267
Z3226
NOMESCO Finland
Physiotherapist
0.4
13.5
53
1402
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.1
12.8
54
180
OAA80, ,
SPAT
2.0
12.7
139
722
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
12.7
473
3483
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.7
12.7
40
111
W43
ICD-10 Finland
Exposure to vibration
+∞
12.5
12
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
3.2
12.2
49
159
N03AX12
ATC
[U] gabapentin; oral
1.8
12.1
210
1270
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
5.3
12.0
24
46
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
3.4
11.8
42
126
DAX08
NOMESCO Finland
Fitting of hearing aid
2.3
11.7
93
426
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.8
11.7
58
212
J43.9
ICD-10 Finland
Emphysema, unspecified
3.7
11.7
36
98
J62.8
ICD-10 Finland
Pneumoconiosis due to other dust containing silica
65.5
11.6
13
*
J30.0
ICD-10 Finland
Vasomotor rhinitis
3.3
11.6
43
133
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.3
11.5
84
372
R05
ICD-10 Finland
Cough
1.7
11.5
272
1790
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
11.3
657
5277
SPAT1312
SPAT
General health counselling
1.6
11.2
378
2705
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
10.9
100
486
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
10.8
59
227
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.1
10.8
102
502
R49.08
ICD-10 Finland
Other specified dysphonia
3.5
10.8
36
104
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
9.7
10.8
21
22
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
10.1
10.5
20
20
R44
ICPC
Respiratory, Preventive immunization/medic
4.0
10.3
29
74
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
10.3
109
560
SPAT1260
SPAT
Consultation of another employee
1.7
10.2
210
1329
R03BA02
ATC
budesonide; inhalant
1.7
10.0
212
1350
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.1
10.0
42
140
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
9.9
329
2336
M50.3
ICD-10 Finland
Other cervical disc degeneration
3.3
9.8
36
111
R01AD12
ATC
fluticasone furoate; nasal
1.5
9.6
366
2675
SPAT1254
SPAT
Administration of medicine
1.7
9.5
171
1041
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.5
543
4301
N02BE01
ATC
paracetamol; systemic, rectal
1.7
9.4
1136
10416
ACC51
NOMESCO Finland
Release of median nerve
2.0
9.3
99
509
356
Kela drug reimbursment
Nintedanib and pirfenidone
8.7
9.3
19
22
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.4
9.2
33
100
J98.1
ICD-10 Finland
Pulmonary collapse
7.8
9.1
20
26
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.9
9.1
42
148
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
9.1
72
331
R49.01
ICD-10 Finland
Functional dysphonia
2.9
9.0
42
149
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.2
8.8
77
368
Z10.0
ICD-10 Finland
Occupational health examination
1.8
8.8
124
702
GAC00
NOMESCO Finland
Biopsy of pleura
9.6
8.8
17
18
M03BX02
ATC
tizanidine; oral
1.4
8.7
741
6267
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
8.6
230
1552
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
8.6
50
200
R03AK11
ATC
formoterol and fluticasone; inhalant
2.8
8.3
41
150
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.5
8.2
51
210
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
8.2
329
2418
SPAT1059
SPAT
Spirometry at the office
2.2
8.2
69
325
A02BC05
ATC
esomeprazole; systemic
1.4
8.1
470
3705
L92
ICPC
Shoulder syndrome
2.9
8.0
37
131
XQ855, ,
SPAT
3.9
8.0
23
60
R05
ICPC
Cough
1.5
8.0
291
2097
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
8.0
230
1576
SPAT1081
SPAT
Cardiorespiratory global assessment
2.1
7.9
70
337
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
7.8
119
690
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.7
7.8
40
150
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
7.7
349
2621
TGA30
NOMESCO Finland
Thoracocentesis
4.4
7.7
19
44
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.4
7.7
49
205
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
7.6
185
1219
J43.2
ICD-10 Finland
Centrilobular emphysema
8.9
7.5
15
17
Z71.8
ICD-10 Finland
Other specified counselling
0.7
7.5
216
3046
SPAT1324
SPAT
Screening procedure
1.6
7.5
162
1035
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.9
7.5
94
513
JN4AD
NOMESCO Finland
Body CT examination
1.6
7.4
160
1021
R03BB07
ATC
umeclidinium bromide; inhalant
4.4
7.4
18
41
A02BC03
ATC
lansoprazole; oral
1.5
7.4
322
2398
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
7.4
305
2248
J39.3
ICD-10 Finland
Upper respiratory tract hypersensitivity reaction, site unspecified
13.4
7.4
12
9
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.0
7.4
31
104
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
7.4
214
1467
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
0.2
7.4
5
308
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.7
7.3
143
890
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
6.9
7.3
17
25
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.2
7.3
57
261
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
3.0
7.3
31
105
J01FA10
ATC
azithromycin; systemic
1.4
7.2
648
5458
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
0.2
7.2
8
363
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
7.1
119
711
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
7.0
306
2278
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
0.1
7.0
*
230
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
0.2
7.0
9
373
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
6.9
118
708
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
6.9
85
462
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.1
6.8
60
288
J01CA04
ATC
amoxicillin; systemic
1.4
6.8
1002
9107
M77.1
ICD-10 Finland
Lateral epicondylitis
1.8
6.8
94
529
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.8
527
4324
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
6.8
147
939
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
6.8
248
1783
UDM02
NOMESCO Finland
Sinoscopy
2.7
6.8
35
132
R03AC13
ATC
formoterol; inhalant
2.2
6.7
56
263
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
0.2
6.7
5
292
XF400
NOMESCO Finland
ECG with 12 standard connections
0.5
6.7
70
1279
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
7.8
6.6
14
18
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.2
6.6
25
79
XG405
NOMESCO Finland
Education on PEF monitoring
3.5
6.6
22
64
A78
ICPC
Infectious disease other/NOS
3.0
6.5
27
90
R06AE07
ATC
cetirizine; oral
1.4
6.5
464
3752
WX400
NOMESCO Finland
Inhalation anesthesy
2.2
6.4
50
229
Z51.5
ICD-10 Finland
Palliative care
1.7
6.4
114
692
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.0
6.4
63
317
SPAT1323
SPAT
Health check-up related to work causing occupational hazard
3.1
6.4
26
86
SPAT1283
SPAT
Restricted health certificate
1.6
6.4
170
1143
L01EX09
ATC
nintedanib; oral
8.2
6.3
13
16
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.6
6.3
36
143
K01
ICPC
Heart pain
3.5
6.3
21
61
J47
ICD-10 Finland
Bronchiectasis
3.0
6.3
27
92
Z57.4
ICD-10 Finland
Occupational exposure to toxic agents in agriculture
+∞
6.3
6
*
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
6.2
46
206
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
6.2
71
376
S63.3
ICD-10 Finland
Traumatic rupture of ligament of wrist and carpus
3.2
6.2
24
77
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
4.0
6.2
17
43
284
Kela drug reimbursment
Nintedanib and pirfenidone
6.3
6.2
15
24
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
6.3
6.2
15
24
WX892
NOMESCO Finland
Monitored bed care
1.7
6.1
102
610
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.0
140
911
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
180
481
4.18
60.74
3.5
2.7
—
—
—
0
0
236
773
3.51
59.22
1.5
1.3
203.09
244.81
u/ml
0.25
219
718
225
797
3.20
49.21
6.7
7.9
24.32
24.41
mmol/l
0.14
219
759
248
932
3.05
48.98
1.5
1.4
—
—
—
0
0
107
265
4.31
39.53
4.8
9.3
104.89
105.41
mmol/l
0.54
100
237
107
265
4.31
39.53
4.8
9.3
11.05
11.37
mmol/l
0.47
100
237
1059
8492
2.32
31.01
5.6
4.3
11.13
11.66
mm/h
0.58
1013
7960
370
2048
2.13
30.45
1.4
1.3
29.47
33.35
iu/ml
0.26
112
625
127
449
3.03
27.26
1.2
1.2
0.25
1.18
u/ml
—
6
27
106
351
3.20
25.42
1.5
1.3
220.52
229.14
miu/ml
0.08
58
157
144
3122
0.39
25.33
3.3
4.3
91.33
86.96
%
1.25
135
3063
138
538
2.75
24.71
4.7
6.7
0.95
0.86
%
2.35
131
505
90
278
3.40
24.13
1.2
1.2
—
—
—
0
0
553
3754
1.82
23.70
3.1
2.8
58.73
82.27
u/l
0.57
516
3517
49
98
5.16
23.40
1.4
1.2
0.12
0.36
u/ml
1.10
38
55
142
581
2.62
23.08
4.6
6.4
1.83
1.65
%
1.59
135
546
265
1432
2.07
22.44
5.0
4.9
31.91
31.88
%
0.01
179
962
72
2008
0.32
21.17
3.2
3.2
4.39
1.35
e6/l
0.96
41
1036
242
1302
2.05
20.59
8.9
7.1
—
—
—
0
0
194
964
2.19
20.29
4.9
3.0
164.67
198.03
ng/l
0.51
188
877
414
2674
1.80
20.19
4.2
3.7
1.02
1.02
kg/l
1.18
304
1783
321
1916
1.90
20.17
1.4
1.3
8.57
12.27
u/ml
0.56
120
758
204
3404
0.52
15.87
3.0
3.4
0.34
0.40
e6/l
0.21
171
2525
110
484
2.39
15.23
1.5
1.8
9.10
7.31
iu/ml
0.20
22
110
600
4533
1.60
15.09
4.3
3.9
37.84
85.93
ng/l
1.46
409
3269
373
5210
0.60
14.86
10.5
11.8
0.00
0.00
e9/l
0.82
337
4264
25
42
6.05
14.35
1.4
1.7
4.01
3.39
mmol/l
0.40
25
36
297
1902
1.73
14.16
1.7
1.8
1199.84
1149.78
nmol/l
0.47
239
1477
81
319
2.64
14.16
1.3
1.2
12.76
4.07
u/ml
—
8
42
1189
10794
2.16
14.14
5.7
5.2
5.87
5.99
mmol/l
3.28
1104
9970
70
260
2.79
13.70
1.4
1.5
—
—
—
0
0
82
333
2.56
13.48
1.3
1.2
47.13
17.48
u/ml
—
6
12
247
1522
1.77
13.42
5.4
9.0
1.73
0.77
mmol/l
6.18
198
1251
249
1539
1.76
13.39
5.5
9.0
11.58
12.16
kpa
1.00
241
1485
249
1539
1.76
13.39
5.5
9.0
4.97
5.12
kpa
1.93
241
1482
319
2112
1.68
13.36
2.4
2.0
—
—
—
0
0
230
1398
1.78
13.07
5.2
9.3
95.82
95.50
%
0.44
222
1356
40
109
3.75
12.98
1.3
1.1
—
52.43
—
0
7
60
214
2.89
12.67
1.3
1.5
—
—
—
0
0
21
34
6.26
12.49
1.5
1.4
16.43
23.19
%
0.51
21
26
698
5612
1.52
12.38
15.5
15.9
1.26
1.28
inr
0.29
612
4695
74
299
2.56
12.30
1.5
1.5
—
—
—
0
0
116
2154
0.49
12.07
2.7
3.1
1.89
0.89
e6/l
1.18
83
1189
66
257
2.65
11.82
1.2
1.2
1.10
1.57
u/ml
—
6
11
158
884
1.90
11.67
4.9
3.9
5.16
5.12
kpa
0.20
150
851
276
3964
0.61
11.39
3.3
3.5
38.09
96.32
e6/l
1.72
238
3061
344
2410
1.58
11.19
1.7
1.7
412.13
32231824.53
pmol/l
2.35
296
2057
798
6699
1.49
10.82
8.8
10.0
4.28
4.21
e9/l
0.24
751
5806
209
1303
1.72
10.74
5.6
9.9
129.00
122.40
g/l
4.20
202
1274
1203
11146
2.03
10.74
19.1
16.9
23.44
26.24
mg/l
2.18
1029
9264
79
353
2.32
10.58
2.1
1.7
—
—
—
0
0
241
1577
1.65
10.29
2.2
1.9
—
—
—
0
0
140
790
1.87
10.04
6.3
12.3
16.93
16.06
%
2.52
134
761
999
8861
1.55
9.82
9.4
8.8
79.27
79.47
u/l
0.04
961
8467
1120
10229
1.68
9.47
5.2
4.9
1.87
1.94
mu/l
0.95
1041
9478
260
3645
0.64
9.16
2.8
3.4
0.74
0.76
ug/l
0.17
156
2422
132
762
1.81
8.80
4.8
3.7
2.02
1.75
mmol/l
0.46
104
562
953
8439
1.48
8.79
4.1
4.0
14.98
14.72
pmol/l
2.65
875
7749
72
343
2.16
8.31
4.4
4.1
3.93
3.97
mmol/l
0.34
72
338
567
4617
1.40
8.07
4.0
3.6
0.00
0.03
estimate
3.03
101
1098
433
3364
1.43
8.05
4.3
3.8
0.00
0.01
estimate
1.34
101
1186
892
7858
1.43
7.98
4.3
3.5
52.02
53.38
u/l
0.18
848
7445
1189
11132
1.78
7.98
5.6
5.2
4.55
4.50
mmol/l
0.74
1110
10472
57
251
2.33
7.95
1.4
1.5
—
—
—
0
0
1200
11285
1.80
7.65
6.1
5.9
2.67
2.65
mmol/l
0.53
1121
10570
90
482
1.93
7.58
5.6
4.1
25.53
24.77
mmol/l
1.83
80
458
37
136
2.77
7.49
5.9
5.0
59.54
56.71
%
0.29
31
120
70
346
2.08
7.38
2.1
1.6
—
—
—
0
0
1180
11078
1.69
7.12
5.5
5.1
1.41
1.39
mmol/l
0.98
1099
10359
35
129
2.76
7.06
2.2
2.6
16.07
18.46
mg/l
0.18
14
57
683
5817
1.37
7.05
7.6
8.2
1.20
1.20
mmol/l
0.10
581
5049
145
2201
0.62
6.99
2.0
3.2
2.43
2.44
mmol/l
0.60
134
1994
621
5215
1.36
6.98
6.5
7.5
1.20
1.20
mmol/l
0.65
566
4841
1236
11771
1.97
6.98
14.1
12.5
26.87
27.49
u/l
0.72
1208
11477
45
190
2.42
6.92
1.0
1.1
1.43
1.54
g/l
1.01
39
175
37
143
2.63
6.83
1.6
1.4
—
—
—
0
0
37
143
2.63
6.83
1.6
1.4
—
—
—
0
0
34
127
2.72
6.70
2.6
1.9
—
—
—
0
0
172
1147
1.58
6.67
2.6
2.3
385.44
377.26
nmol/l
0.20
158
1079
1262
12139
2.26
6.45
28.7
25.5
246.51
243.43
e9/l
0.98
1251
11928
48
216
2.27
6.42
1.1
1.1
1.28
1.59
u/ml
0.20
27
118
36
142
2.58
6.40
1.6
1.5
—
—
—
0
0
37
148
2.54
6.39
1.7
1.4
—
—
—
0
0
1262
12143
2.25
6.38
28.5
25.4
91.24
91.25
fl
0.03
1251
12030
46
204
2.30
6.36
5.9
4.7
1.08
1.39
%
0.35
39
188
17
42
4.09
6.36
1.4
1.4
1484.43
58.87
ug/l
—
9
17
1262
12145
2.24
6.34
28.6
25.5
4.55
4.53
e12/l
0.66
1250
11901
1262
12145
2.24
6.34
28.8
26.1
41.05
40.78
%
1.01
1252
12022
1262
12148
2.23
6.29
28.8
25.7
138.12
136.95
g/l
2.05
1252
12036
1262
12148
2.23
6.29
28.7
25.5
7.04
6.82
e9/l
1.46
1250
11899
1133
10592
1.53
6.28
4.6
4.4
1.25
1.30
mmol/l
1.30
1048
9846
837
7430
1.35
6.23
4.7
4.3
13.52
667.58
e6/l
1.21
23
107
210
1485
1.49
6.21
2.3
1.9
—
—
—
0
0
797
7029
1.34
6.16
5.4
5.6
6.61
6.76
mmol/l
1.45
744
6694
35
139
2.56
6.14
2.5
1.9
—
—
—
0
0
38
158
2.45
6.07
1.2
1.1
2.91
2.76
u/ml
0.03
22
74
36
146
2.51
6.06
1.7
1.4
—
—
—
0
0
160
1074
1.56
6.02
2.9
3.0
67.41
66.56
g/l
0.79
145
1001
719
6259
1.33
6.00
7.8
7.1
11.48
12.17
umol/l
0.86
683
6018
96
567
1.75
5.96
1.6
2.0
1.44
2.76
ug/l
0.67
84
515
36
148
2.47
5.90
1.7
1.4
—
—
—
0
0
1201
11410
1.67
5.86
21.4
20.3
4.02
3.99
mmol/l
3.68
1174
11194
83
472
1.81
5.86
3.5
3.1
24.77
24.72
mmol/l
0.05
83
466
1237
11856
1.86
5.75
24.5
21.9
80.32
82.19
umol/l
1.45
1228
11740
76
424
1.84
5.71
4.4
3.9
1.32
1.40
mmol/l
0.34
76
414
452
3698
1.34
5.70
2.6
2.3
197.37
228.10
u/l
0.29
432
3522
1198
11386
1.65
5.69
21.5
20.1
139.57
139.68
mmol/l
0.88
1174
11190
1133
10640
1.50
5.63
6.9
6.6
38.86
39.42
mmol/mol
1.70
1053
10003
29
111
2.65
5.50
1.4
1.3
235942.94
93377.15
e6/l
0.26
16
75
17
47
3.65
5.49
1.2
1.6
—
—
—
0
0
604
5174
1.31
5.44
5.8
5.7
35.00
35.54
g/l
1.46
559
4899
23
78
2.98
5.43
1.6
1.5
—
—
—
0
0
23
78
2.98
5.43
1.6
1.5
—
—
—
0
0
91
545
1.72
5.40
1.7
2.1
38.57
39.21
u/l
0.10
74
489
144
972
1.54
5.29
2.9
3.0
10.76
10.92
g/l
0.16
131
905
437
3598
1.32
5.17
3.9
3.3
959.97
1373.51
ng/l
3.21
385
3125
29
117
2.51
4.98
1.1
1.3
—
—
—
0
0
34
148
2.33
4.96
1.1
1.1
0.55
3.04
u/ml
2.58
16
58
20
66
3.06
4.96
1.1
1.2
—
74.25
%
—
0
8
35
155
2.29
4.92
1.4
1.5
103028.85
70270.78
e6/l
0.32
26
87
27
106
2.58
4.90
2.4
1.7
—
—
—
0
0
27
106
2.58
4.90
2.4
1.7
—
—
—
0
0
27
106
2.58
4.90
2.4
1.7
—
—
—
0
0
16
47
3.43
4.75
1.3
1.2
—
—
—
0
0
48
248
1.97
4.59
1.2
1.2
88.42
45.44
u/ml
—
5
21
692
6121
1.28
4.57
4.2
3.6
0.00
4.64
estimate
1.33
119
1300
47
243
1.97
4.49
4.1
3.7
21.36
29.84
mg/l
1.31
34
169
243
1868
1.37
4.47
1.7
1.5
—
—
—
0
0
692
6140
1.27
4.38
4.2
3.6
0.00
0.26
estimate
0.53
112
1206
682
6049
1.27
4.29
4.1
3.6
0.00
0.00
estimate
0.50
116
1294
30
134
2.27
4.17
1.1
1.1
0.13
0.38
u/ml
0.58
13
43
36
176
2.08
4.03
1.2
1.1
0.32
1.32
u/ml
1.65
18
87
26
112
2.35
3.94
1.8
1.7
—
—
—
0
0
88
573
1.57
3.83
3.5
3.5
25.66
25.11
mmol/l
0.70
80
550
10
20
5.03
3.69
1.3
1.1
—
—
—
0
0
10
20
5.03
3.69
1.3
1.1
—
—
—
0
0
11
25
4.43
3.62
2.5
1.7
—
—
—
0
0
43
753
0.56
3.60
2.3
4.1
24.00
24.13
mmol/l
0.10
43
748
76
486
1.60
3.59
2.6
2.0
—
—
—
0
0
1028
10803
0.77
3.50
13.3
16.3
81.83
81.65
ml/min/173m2
0.11
973
10017
56
333
1.71
3.50
1.5
1.3
—
—
—
0
0
312
2569
1.28
3.49
1.8
1.7
1.14
1.35
mg/l
0.63
247
2013
51
297
1.75
3.43
2.0
2.4
144.20
130.37
g/l
4.02
45
237
386
3277
1.25
3.33
3.2
3.0
346.89
356.47
umol/l
1.10
341
2912
16
59
2.73
3.33
1.6
1.5
—
—
—
0
0
16
59
2.73
3.33
1.6
1.5
—
—
—
0
0
763
6967
1.23
3.31
3.3
2.9
—
—
—
0
0
22
464
0.47
3.30
2.4
2.8
0.98
1.37
g/l
0.22
17
411
56
339
1.68
3.30
1.5
1.4
—
—
—
0
0
70
451
1.58
3.23
2.2
1.8
—
—
—
0
0
33
172
1.94
3.16
1.0
1.1
—
—
—
0
0
665
6010
1.22
3.11
5.5
5.8
4.21
2.67
ug/l
0.48
596
5433
399
3424
1.24
3.09
1.6
1.7
19.19
19.60
nmol/l
0.22
335
2924
103
1426
0.70
3.08
2.2
2.9
8.23
8.19
umol/l
0.01
91
1287
92
640
1.47
3.00
1.5
1.4
—
—
—
0
0
609
5470
1.21
2.99
2.9
3.1
165.58
146.01
ug/l
0.56
569
5127
15
57
2.65
2.97
3.3
3.5
—
—
—
0
0
40
228
1.78
2.93
2.4
1.8
—
—
—
0
0
31
163
1.92
2.91
1.3
2.1
—
2102.86
—
0
7
576
5160
1.21
2.87
2.1
2.2
98.25
94.29
pmol/l
1.16
338
2934
32
172
1.88
2.83
1.4
1.6
—
—
—
0
0
20
409
0.48
2.79
1.2
1.3
—
—
—
0
0
463
4090
1.20
2.62
4.1
4.3
5.97
9.56
mg/mmol
1.78
285
2707
0
69
0.00
2.60
0.0
1.5
—
—
—
0
0
0
69
0.00
2.60
0.0
1.2
—
88.20
—
0
59
50
315
1.61
2.58
1.7
1.6
9906.44
14771.69
e6/l
0.72
41
231
255
3030
0.80
2.54
2.7
2.5
—
—
—
0
0
478
4258
1.19
2.43
3.3
3.6
8.19
8.26
mmol/l
0.13
406
3617
0
65
0.00
2.42
0.0
1.2
—
20.35
—
0
55
136
1054
1.32
2.40
3.3
2.4
7.76
8.13
ug/l
0.09
117
968
191
1549
1.27
2.39
5.1
4.5
255.98
242.15
u/l
0.66
175
1481
31
522
0.58
2.33
3.7
2.7
2.88
3.73
g/l
3.20
26
487
381
3337
1.20
2.31
3.3
3.1
0.00
0.05
estimate
1.10
98
1030
25
134
1.88
2.27
1.6
1.6
55.19
62.03
%
0.38
16
90
26
142
1.85
2.24
1.3
1.7
22.25
35.28
ng/l
0.86
26
142
18
86
2.11
2.23
1.1
1.2
—
—
—
0
0
451
4024
1.18
2.21
4.5
3.4
31.84
34.01
u/l
0.51
428
3806
18
87
2.08
2.17
1.1
1.2
—
—
—
0
0
26
449
0.57
2.17
4.1
2.7
9.51
10.75
g/l
0.70
20
412
7
19
3.70
2.15
1.0
1.3
—
—
—
0
0
233
2745
0.82
2.11
3.0
2.8
4.03
4.66
e6/l
0.39
219
2492
124
968
1.31
2.10
2.5
2.9
70.38
65.85
ml/min/173m2
0.62
53
421
16
75
2.15
2.09
1.3
1.2
0.51
0.51
ratio
—
9
44
30
493
0.60
2.08
3.8
2.7
2.10
2.91
g/l
4.47
25
459
611
5615
1.17
2.04
3.0
3.0
—
—
estimate
—
0
0
5
11
4.56
1.94
9.2
5.1
—
—
—
0
0
48
325
1.50
1.88
1.4
1.3
—
—
—
0
0
15
72
2.10
1.86
1.6
1.2
—
—
—
0
0
359
3182
1.18
1.86
2.4
2.3
3.19
2.74
mg/l
2.06
318
2765
97
1243
0.76
1.82
2.5
3.4
—
—
—
0
0
34
522
0.64
1.80
3.4
2.7
7.00
7.19
g/l
0.29
29
487
34
522
0.64
1.80
3.4
2.7
4.75
4.16
g/l
0.70
29
488
531
4870
1.15
1.75
5.2
4.7
22.35
21.46
%
0.70
262
2446
230
1972
1.20
1.74
1.8
2.2
27.73
29.88
s
7.65
220
1922
7
24
2.93
1.72
1.1
1.1
—
—
—
0
0
15
75
2.01
1.70
1.3
1.4
5.73
7.93
ug/l
0.75
15
63
289
2537
1.18
1.68
1.3
1.3
3.30
1.66
u/ml
0.49
81
710
127
1027
1.26
1.68
3.0
2.7
0.21
0.33
e6/l
0.98
122
982
170
1422
1.22
1.66
2.2
2.6
115.53
127.60
ug/g
0.24
129
1150
7
25
2.81
1.65
5.3
8.7
11.07
10.79
%
—
7
25
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
21
122
1.73
1.55
1.4
1.2
—
—
—
0
0
50
357
1.42
1.54
1.4
1.5
298.77
272.87
ug/g
0.40
29
216
13
64
2.04
1.54
1.7
3.0
502.85
1181.98
u/ml
1.10
13
64
106
854
1.26
1.47
1.8
1.7
—
—
—
0
0
53
388
1.38
1.43
1.5
1.5
0.25
0.04
iu/ml
—
5
60
10
46
2.18
1.40
1.2
1.1
—
—
—
0
0
9
41
2.20
1.37
1.9
3.3
8.88
10.21
kpa
—
9
41
9
41
2.20
1.37
1.9
3.3
4.60
4.95
kpa
—
9
41
227
1988
1.17
1.36
2.0
2.8
2.32
2.27
g/l
0.70
207
1842
136
1138
1.22
1.35
2.0
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
441
0.67
1.35
2.7
2.8
0.27
0.34
iu/ml
0.76
20
232
44
316
1.41
1.34
3.5
3.2
8.17
7.96
kpa
0.35
44
307
13
68
1.92
1.33
2.1
2.5
—
—
—
0
0
9
44
2.05
1.27
1.1
1.1
—
—
—
0
0
22
138
1.60
1.26
2.1
2.8
—
—
—
0
0
145
1234
1.20
1.23
1.5
1.5
—
—
—
0
0
8
37
2.17
1.21
1.1
1.1
—
—
—
0
0
11
57
1.94
1.17
5.1
3.3
1.68
1.18
%
0.23
11
57
25
364
0.68
1.11
2.1
1.8
—
—
—
0
0
63
793
0.78
1.10
1.9
1.7
—
—
—
0
0
67
532
1.27
1.10
1.7
1.9
—
—
—
0
0
30
210
1.44
1.09
3.2
3.2
0.87
0.84
nmol/l
0.11
24
165
7
33
2.13
1.05
5.3
9.1
5.66
5.41
kpa
—
7
33
15
91
1.66
1.00
1.0
1.1
—
4.87
nmol/l
—
0
16
24
164
1.47
0.99
1.3
1.0
—
—
—
0
0
45
344
1.32
0.99
1.4
1.3
—
—
—
0
0
0
29
0.00
0.97
0.0
1.8
—
—
—
0
0
35
258
1.37
0.97
2.2
2.7
18.20
16.41
%
3.11
35
250
9
51
1.77
0.94
1.3
1.2
3.78
9.63
mm/h
—
9
51
6
27
2.23
0.93
3.7
3.8
4.17
5.37
ug/l
—
6
27
76
627
1.23
0.92
3.9
3.8
4.59
4.54
pmol/l
0.23
71
560
14
86
1.63
0.91
1.1
1.1
—
—
—
0
0
6
29
2.07
0.89
1.0
1.4
—
—
—
0
0
140
1227
1.16
0.88
2.1
2.0
—
—
—
0
0
36
272
1.33
0.88
1.4
2.1
2.28
4.80
iu/l
3.04
12
110
32
425
0.75
0.87
1.7
1.6
1021.20
983.87
mu/l
0.08
26
353
34
255
1.34
0.87
1.2
1.3
29.89
38.59
u/l
0.22
27
223
95
808
1.19
0.86
3.4
3.2
131.26
129.31
g/l
0.35
89
789
62
505
1.24
0.86
1.0
1.0
—
—
—
0
0
37
282
1.32
0.86
1.2
1.3
1.66
41.74
e6/l
1.12
29
210
76
635
1.21
0.84
1.8
2.0
—
—
—
0
0
10
57
1.76
0.83
1.0
1.1
—
—
—
0
0
256
2343
1.12
0.83
5.3
4.0
81.74
493.39
ng/l
7.25
206
1856
49
390
1.27
0.83
1.3
1.3
10.16
8.28
u/l
0.51
41
311
16
237
0.67
0.82
1.4
1.5
1.02
1.14
ratio
—
9
148
16
237
0.67
0.82
1.4
1.5
1.22
1.11
ratio
—
8
148
16
237
0.67
0.82
1.4
1.5
0.94
0.94
ratio
—
8
148
16
235
0.68
0.79
1.4
1.4
—
—
—
0
0
141
1248
1.15
0.79
3.6
4.5
43.10
23.62
ug/l
0.33
120
1031
0
24
0.00
0.79
0.0
9.0
—
6.01
—
0
24
520
4938
1.09
0.79
2.4
2.4
76.34
75.75
nmol/l
0.19
469
4472
8
48
1.67
0.78
5.3
2.1
—
—
—
0
0
8
48
1.67
0.78
5.3
2.1
—
—
—
0
0
95
816
1.18
0.78
2.8
2.4
18.37
18.71
au/ml
0.02
13
78
19
131
1.46
0.78
2.4
1.5
245.64
342.26
mu/l
0.88
14
103
37
287
1.30
0.77
1.2
1.4
451.44
833.83
e6/l
0.30
32
223
31
402
0.77
0.74
1.7
1.6
57.49
12.59
u/ml
—
9
110
212
2317
0.90
0.73
1.4
1.5
2.73
2.54
g/l
0.65
148
1484
15
219
0.68
0.73
3.5
3.8
6.99
9.69
pmol/l
0.62
15
219
35
272
1.29
0.73
1.4
1.5
—
—
—
0
0
7
40
1.75
0.71
1.6
1.3
7.33
9.06
ug/l
—
7
40
84
722
1.17
0.71
1.2
1.2
79.02
154.56
u/ml
1.85
43
280
137
1224
1.13
0.69
2.3
2.4
0.20
0.21
g/l
0.71
129
1150
909
9311
0.92
0.68
18.6
20.7
13.68
13.62
%
0.57
901
9213
39
312
1.26
0.67
3.5
3.0
32.85
33.33
umol/l
0.06
33
276
13
86
1.52
0.66
1.1
1.1
86.77
106.28
pmol/l
0.92
13
86
20
270
0.74
0.65
1.3
1.2
—
—
—
0
0
25
189
1.33
0.64
1.4
1.3
—
—
—
0
0
17
120
1.42
0.64
1.2
1.1
—
—
—
0
0
13
189
0.68
0.64
2.2
2.7
29.99
6.30
u/ml
0.41
13
184
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
19
138
1.38
0.62
1.2
1.1
—
—
—
0
0
8
49
1.64
0.62
5.3
2.1
—
—
—
0
0
509
4872
1.07
0.61
2.0
1.9
1.25
1.37
mmol/l
3.26
433
4094
17
122
1.40
0.60
1.1
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.8
—
0.58
—
0
14
81
924
0.87
0.58
1.6
1.8
3.44
3.44
mmol/l
0.02
54
674
8
53
1.51
0.58
1.1
2.0
45.27
40.85
g/l
—
8
53
167
1528
1.11
0.58
1.7
1.9
1.51
1.52
%
0.03
143
1333
8
54
1.48
0.57
1.1
1.0
1116.75
1471.43
miu/ml
—
8
54
955
9357
1.08
0.57
23.5
21.4
334.20
333.20
g/l
3.11
950
9314
11
73
1.51
0.56
1.2
1.1
1.18
1.12
u/l
—
5
38
22
285
0.77
0.56
1.4
1.1
—
—
—
0
0
22
284
0.77
0.55
1.4
1.1
—
—
—
0
0
113
1254
0.89
0.54
1.9
2.1
4.11
3.55
ratio
0.43
86
999
9
63
1.43
0.52
4.8
1.9
—
—
—
0
0
9
63
1.43
0.52
4.8
1.9
—
—
—
0
0
9
63
1.43
0.52
4.8
1.9
—
—
—
0
0
9
63
1.43
0.52
4.8
1.9
—
—
—
0
0
9
134
0.67
0.52
2.8
4.0
—
—
—
0
0
17
126
1.35
0.51
1.3
1.3
—
—
—
0
0
80
903
0.88
0.51
6.3
10.8
93.72
94.01
%
0.24
80
898
7
47
1.49
0.47
1.1
1.3
81.28
127.80
nmol/l
—
7
33
42
356
1.19
0.46
1.8
2.1
4592.73
4721.80
u/l
0.01
15
149
38
450
0.84
0.46
1.8
1.8
2.94
3.90
mg/l
0.72
29
332
24
192
1.25
0.45
1.3
1.5
—
—
—
0
0
37
312
1.19
0.43
13.0
5.9
306.09
795.04
iu/ml
0.58
11
46
5
31
1.62
0.43
1.0
1.0
27.74
44.07
u/ml
—
5
31
225
2121
1.07
0.42
2.1
2.8
12.72
13.45
umol/l
0.82
209
1985
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
196
1844
1.07
0.39
2.0
2.9
22.83
23.77
%
0.42
177
1727
7
105
0.66
0.39
1.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
79
873
0.90
0.39
6.3
10.9
0.72
0.62
%
1.75
79
867
156
1458
1.08
0.38
2.0
2.4
14.07
13.27
nmol/l
0.63
133
1308
8
112
0.71
0.37
1.1
1.2
—
—
—
0
0
5
37
1.35
0.37
1.0
1.8
—
92.13
—
0
23
5
37
1.35
0.37
1.0
1.2
—
88.48
—
0
23
16
125
1.28
0.37
2.9
3.0
1004.75
1052.48
mg
0.03
16
125
10
72
1.39
0.37
2.1
2.4
—
—
—
0
0
24
289
0.83
0.36
2.0
1.6
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
81
885
0.91
0.33
3.1
4.1
1.23
1.22
mmol/l
0.38
66
773
401
3881
1.05
0.32
3.0
3.7
2.33
2.34
mmol/l
0.99
361
3538
10
132
0.76
0.32
1.3
1.2
1.22
1.48
nmol/l
—
10
120
24
284
0.84
0.32
1.7
1.5
—
—
—
0
0
16
197
0.81
0.31
1.1
1.1
1.00
61.57
iu/ml
—
7
42
121
1292
0.93
0.30
3.3
3.9
6.00
5.81
kpa
1.07
115
1255
50
557
0.89
0.30
1.5
1.7
0.21
0.32
mg/l
1.35
24
278
14
174
0.80
0.29
1.1
1.1
—
—
—
0
0
19
157
1.21
0.29
2.3
2.5
9.00
42.91
iu/ml
—
5
17
11
141
0.78
0.29
2.4
1.4
0.61
0.62
nmol/l
0.03
11
136
12
94
1.28
0.28
1.1
1.5
157.03
172.34
pmol/l
0.19
12
94
51
461
1.11
0.27
3.9
4.1
47.39
95.03
mg/l
0.71
43
392
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
84
903
0.93
0.26
6.1
10.6
1.55
1.28
%
2.10
84
897
5
71
0.70
0.26
1.0
1.4
—
47.50
—
0
8
38
422
0.90
0.23
1.0
1.1
1.56
1.52
g/l
0.33
38
422
27
306
0.88
0.23
1.9
1.8
—
—
—
0
0
5
42
1.19
0.21
1.2
1.0
—
551.22
ng/l
—
0
9
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
4.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
8
103
0.78
0.21
1.0
1.2
—
—
—
0
0
57
615
0.92
0.21
1.9
2.0
1.35
1.52
g/l
0.76
47
536
32
287
1.12
0.21
2.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
2.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
2.8
—
0.46
—
0
13
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
50
462
1.09
0.19
3.9
4.1
58.44
64.57
mg/l
0.14
42
392
6
52
1.15
0.19
1.8
1.0
—
—
—
0
0
6
53
1.13
0.18
1.5
2.5
406.67
1071.23
e6/l
—
6
44
23
204
1.13
0.18
1.3
1.7
—
—
—
0
0
25
224
1.12
0.17
1.1
1.1
—
1.19
—
0
12
8
70
1.14
0.16
1.4
1.6
11.50
4.83
u/l
—
8
60
6
77
0.78
0.15
1.3
1.6
—
—
—
0
0
6
79
0.76
0.15
1.3
1.6
—
—
—
0
0
128
1234
1.04
0.15
6.9
8.6
8.83
10.42
mmol/l
2.54
122
1192
121
1256
0.96
0.14
3.3
4.0
2.29
1.74
mmol/l
0.99
96
1076
16
181
0.88
0.14
1.1
1.2
4.00
6.34
u/ml
—
5
82
32
295
1.09
0.14
1.4
1.5
—
—
—
0
0
53
501
1.06
0.13
1.5
1.3
—
—
—
0
0
122
1184
1.03
0.11
2.6
2.8
72.71
69.25
e9/l
0.53
113
891
10
86
1.16
0.11
1.6
1.7
—
—
—
0
0
32
299
1.07
0.11
2.3
2.4
68.63
134.78
ug/min
0.60
14
177
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
5
47
1.06
0.09
1.6
2.1
6770.00
3953.45
e6/l
—
5
29
215
2113
1.02
0.09
4.0
3.5
0.81
0.82
mmol/l
0.39
205
2021
28
263
1.07
0.08
1.3
1.2
177.25
269.11
u/ml
3.13
12
158
13
117
1.11
0.08
1.0
1.0
—
—
—
0
0
6
74
0.81
0.07
1.0
1.4
—
412.86
—
0
7
87
847
1.03
0.07
4.0
4.7
79.57
99.71
ng/l
1.74
76
756
7
83
0.84
0.07
1.0
1.5
—
22.27
—
0
15
13
118
1.10
0.07
1.0
1.2
—
—
—
0
0
9
103
0.87
0.06
1.4
1.4
—
—
—
0
0
14
152
0.92
0.06
1.6
1.6
47.24
54.86
ug/l
0.39
14
152
16
171
0.93
0.05
1.6
1.8
—
—
—
0
0
40
387
1.03
0.04
2.1
1.7
—
—
—
0
0
16
170
0.94
0.04
2.1
1.6
—
—
—
0
0
43
418
1.03
0.04
4.0
3.8
8.42
3.47
ratio
0.37
33
237
20
194
1.03
0.00
2.1
1.9
1.55
1.68
mmol/l
0.41
20
185
13
127
1.02
0.00
1.2
2.2
3.26
7.13
umol/l
—
5
91
16
165
0.97
0.00
1.1
1.0
0.97
2.30
eliau/ml
—
6
65
11
115
0.96
0.00
1.3
1.3
43.55
52.45
u/l
0.69
11
104
0
6
0.00
0.00
0.0
1.0
—
7.12
—
0
6
0
6
0.00
0.00
0.0
1.0
—
20.65
—
0
6
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
1.32
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
0.00
1.3
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
40.72
—
0
6
6
67
0.90
-0.00
1.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
70
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
-0.00
3.2
3.0
27.00
34.32
umol/l
—
5
33
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.2
—
404.11
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
1.3
2.3
81.78
131.21
ng/l
—
6
59
9
99
0.91
-0.00
1.6
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
88
0.91
-0.00
1.3
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
3.00
—
0
8
0
9
0.00
-0.00
0.0
1.0
—
51.11
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
171
1710
1.00
-0.00
5.7
7.0
1.02
1.03
mmol/l
0.23
155
1606
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_OCCUPAT_EXPOS_RISK_ – Occupational exposure to risk-factors
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).